Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma

To evaluate the National Comprehensive Cancer Network (NCCN) International Prognostic Index (IPI), we analyzed 284 patients treated with the combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in our institution in Japan. Their 5-year overall survival (OS) b...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2016-01-01
coleção:	Leukemia Research Reports
Assuntos:	NCCN-IPI DLBCL Rituximab Albumin
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2213048916300140
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!